Ikarian Capital »

Proqr Thrapeutics N V shs euro shares owned by Ikarian Capital

Quarter-by-quarter ownership of Proqr Thrapeutics N V shs euro (PRQR) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Proqr Thrapeutics N V shs euro

Tip: Access up to 7 years of quarterly data

All positions including Proqr Thrapeutics N V shs euro held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proqr Thrapeutics N V shs euro by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.9M 892k 2.13
2025-06-30 $1.8M 868k 2.04
2024-09-30 $880k 484k 1.82
2024-06-30 $803k 484k 1.66
2024-03-31 $1.1M 484k 2.27
2023-12-31 $936k 473k 1.98
2023-09-30 $614k 473k 1.30
2023-06-30 $766k 473k 1.62
2023-03-31 $1.0M 473k 2.13
2022-12-31 $1.6M 423k 3.70

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Proqr Thrapeutics N V shs euro

Adage Capital Partners GP
Privium Fund Management B.V.
Affinity Asset Advisors
Morgan Stanley
Standard Life Aberdeen
Sio Capital Management
Kynam Capital Management
DAFNA Capital Management
Siren
Arrowpoint Asset Management
Platinum Investment Mangement
M28 Capital Management
Ikarian Capital
Point72 Asset Management
Citadel Advisors

View all funds holding Proqr Thrapeutics N V shs euro